Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China · Delayed Price · Currency is CNY 14.22
+0.11 (0.78%)
At close: Jul 14, 2025, 2:57 PM CST
SHE:301408 Revenue
Anhui Huaren Health Pharmaceutical had revenue of 1.27B CNY in the quarter ending March 31, 2025, with 14.71% growth. This brings the company's revenue in the last twelve months to 4.69B, up 15.74% year-over-year. In the year 2024, Anhui Huaren Health Pharmaceutical had annual revenue of 4.53B with 19.34% growth.
Revenue (ttm)
4.69B
Revenue Growth
+15.74%
P/S Ratio
1.21
Revenue / Employee
591.95K
Employees
7,930
Market Cap
5.69B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |